These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21856394)

  • 41. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.
    Choi YS; Lee JY; Suh JS; Kwon YM; Lee SJ; Chung JK; Lee DS; Yang VC; Chung CP; Park YJ
    Biomaterials; 2010 Feb; 31(6):1429-43. PubMed ID: 19954842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
    Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
    J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
    Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
    Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
    Li H; Tsui T
    Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
    Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
    J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
    Katas H; Abdul Ghafoor Raja M; Ee LC
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of a G protein-coupled receptor through efficient peptide-mediated siRNA delivery.
    Hoyer J; Neundorf I
    J Control Release; 2012 Aug; 161(3):826-34. PubMed ID: 22626516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-penetrating cationic siRNA and lipophilic derivatives efficient at nanomolar concentrations in the presence of serum and albumin.
    Perche P; Nothisen M; Bagilet J; Behr JP; Kotera M; Remy JS
    J Control Release; 2013 Aug; 170(1):92-8. PubMed ID: 23639452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
    Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymer nanocarrier system for endosome escape and timed release of siRNA with complete gene silencing and cell death in cancer cells.
    Gu W; Jia Z; Truong NP; Prasadam I; Xiao Y; Monteiro MJ
    Biomacromolecules; 2013 Oct; 14(10):3386-9. PubMed ID: 23992391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
    Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
    Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure.
    Tamura A; Oishi M; Nagasaki Y
    Biomacromolecules; 2009 Jul; 10(7):1818-27. PubMed ID: 19505137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.